anmelden
FTSE All-Share
5.789,82
PKT
+3,09
PKT
+0,05
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.02.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 07.02.17 | Glencore Underweight | JP Morgan Chase & Co. | |
| 07.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 07.02.17 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 07.02.17 | BP buy | UBS AG | |
| 07.02.17 | Rio Tinto buy | UBS AG | |
| 07.02.17 | Rio Tinto buy | Deutsche Bank AG | |
| 07.02.17 | HSBC Hold | Deutsche Bank AG | |
| 07.02.17 | Lloyds Banking Group Hold | Deutsche Bank AG | |
| 06.02.17 | Rio Tinto buy | UBS AG | |
| 06.02.17 | Lloyds Banking Group Hold | Deutsche Bank AG | |
| 06.02.17 | Barclays buy | Deutsche Bank AG | |
| 06.02.17 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 06.02.17 | GSK Equal-Weight | Morgan Stanley | |
| 06.02.17 | Prudential overweight | Barclays Capital | |
| 06.02.17 | Glencore Neutral | Macquarie Research | |
| 06.02.17 | Rio Tinto Outperform | Macquarie Research | |
| 06.02.17 | AstraZeneca buy | Deutsche Bank AG | |
| 06.02.17 | Shell (ex Royal Dutch Shell) buy | Deutsche Bank AG | |
| 06.02.17 | Barclays buy | HSBC | |
| 06.02.17 | Lloyds Banking Group buy | HSBC | |
| 03.02.17 | Vodafone Group buy | Deutsche Bank AG | |
| 03.02.17 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 03.02.17 | HSBC Neutral | UBS AG | |
| 03.02.17 | Vodafone Group buy | UBS AG | |
| 03.02.17 | Glencore Underweight | JP Morgan Chase & Co. | |
| 03.02.17 | Vodafone Group overweight | JP Morgan Chase & Co. | |
| 03.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 03.02.17 | Shell (ex Royal Dutch Shell) buy | S&P Capital IQ | |
| 03.02.17 | Vodafone Group overweight | Barclays Capital | |
| 03.02.17 | Glencore buy | HSBC | |
| 03.02.17 | Shell (ex Royal Dutch Shell) overweight | Barclays Capital | |
| 03.02.17 | Shell (ex Royal Dutch Shell) overweight | Barclays Capital | |
| 03.02.17 | Glencore buy | Citigroup Corp. | |
| 03.02.17 | Vodafone Group buy | Goldman Sachs Group Inc. | |
| 03.02.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 03.02.17 | Glencore Neutral | Goldman Sachs Group Inc. | |
| 03.02.17 | Shell (ex Royal Dutch Shell) Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.02.17 | Glencore Sell | S&P Capital IQ | |
| 02.02.17 | AstraZeneca buy | UBS AG |
